Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptors-Reference-Cited by-同舟云学术

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptors

Published:2016 Issue: Volume:3 Page:16003
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Hanauer Jan RH,Gottschlich Lisa,Riehl Dennis,Rusch Tillmann,Koch Vivian,Friedrich Katrin,Hutzler Stefan,Prüfer Steffen,Friedel Thorsten,Hanschmann Kay-Martin,Münch Robert C,Jost Christian,Plückthun Andreas,Cichutek Klaus,Buchholz Christian J,Mühlebach Michael D

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference75 articles.

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11;Ferlay,2013

2. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer;Goldenberg;Clin Ther,1999

3. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways;Eroles;Cancer Treat Rev,2012

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor;Meden;Eur J Obstet Gynecol Reprod Biol,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

2. Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer;Anticancer Research;2023-11-29

3. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy;Journal of Translational Medicine;2023-07-25

4. Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story;Cancers;2022-06-30

5. Measles Virus as a Vector Platform for Glioblastoma Immunotherapy (Review);Drug development & registration;2022-02-23